Company: GMRE
Filing Date: 2025-11-14
Form Type: 424B5
Source: 0001104659-25-112543
Chunk: 50

Company: Global Medical REIT Inc.
Filing Date: 2025-11-14
Form: 424B5
Chunk 50
---
 on Ownership and Transfer.”

Our common stock is listed on the New York Stock
Exchange, or the NYSE, under the symbol “GMRE.” Our 7.50% Series A Cumulative Redeemable Preferred Stock is listed on the
NYSE under the symbol “GMRE PrA,” The last reported sale price of our common stock on the NYSE on February 28, 2024 was $8.76
per share. We have not yet determined whether any of the other securities that may be offered by this prospectus will be listed on any
exchange, inter-dealer quotation system or over-the-counter system. If we decide to seek a listing for any of those securities, that will
be disclosed in a prospectus supplement.

Investing in our securities involves risks. Before making a decision to invest in our securities, you should carefully consider the risks described under the section entitled “Risk Factors” on page 6 of this prospectus and included in our most recent Annual Report on Form 10-K, subsequent Quarterly Reports on Form 10-Q and other documents filed by us with the Securities and Exchange Commission, including any risks described in any accompanying prospectus supplement.

Neither the U.S. Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus or any accompanying prospectus supplement is truthful or complete. Any representation to the contrary is a criminal offense.

<div align='center'>The date of this prospectus is April 4,
2024

TABLE OF CONTENTS</div>

Page

| About This Prospectus                                            |  1 |
| Incorporation by Reference of Information Filed with the SEC     |  1 |
| Where You Can Find More Information                              |  2 |
| Cautionary Note Regarding Forward-Looking Statements             |  2 |
| Global MedicaL REIT Inc.                                         |  5 |
| Risk Factors                                                     |  6 |
| Use of Proceeds                                                  |  7 |
| Description of Capital Stock                                     |  8 |
| Description of Debt Securities                                   | 19 |
| Legal Ownership of Securities                                    | 30 |
| Certain Provisions of Maryland Law and of Our Charter and Bylaws | 33 |
| Material U.S. Federal Income Tax Considerations                  | 38 |
| Plan of Distribution                                             | 66 |
| Legal Matters                                                    | 69 |
| Experts                                                          | 69 |

Unless otherwise indicated or unless the context
requires otherwise, all references in this